Ads
related to: pfizer stock price
Search results
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 13 hours agoBecause of this, empirical studies indicate a strong correlation between trends in earnings estimate...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 7 hours agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 5 days agoFirst, there's a chance that Pfizer stock has significant upside from here. The company's COVID-19...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 2 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
Investing in Pfizer Inc.
Knox Daily· 5 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 3 days agoAnalysts expect substantially higher revenue potential by the end of the decade, thanks to those...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 2 days agoBear in mind, the business brought in...flow of about $9 billion over the trailing 12 months alone....
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 1 day agoNext earnings are expected to be released in 75 days. What Analysts Are Saying About Pfizer Over the past month, 3 industry analysts have shared their insights on this < ...
These Healthcare Stocks Could Make A Great Addition To Any Passive Income Portfolio
Benzinga via Yahoo Finance· 9 hours agoHealthcare stocks could make an attractive addition to your portfolio in May 2024, thanks to their...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 9 hours ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
